Jallal Bahija 4

What Happened
Jallal Bahija, a member of the Elevance Health, Inc. board of directors, was granted 563 deferred stock units (reported as an award) on May 13, 2026. The Form 4 records the acquisition price as $0 and the reported dollar amount for the transaction as $0. This was an equity award (not an open-market purchase or sale) issued under the company’s director compensation program.

Key Details

• Transaction date: 2026-05-13; Form 4 filed 2026-05-15 (appears timely).
• Transaction type/code: Award/Grant (A).
• Amount: 563 deferred stock units; acquisition price reported $0; total reported value $0.
• Shares owned after transaction: not specified in this filing.
• Footnotes: F1 — units are deferred stock units under the Board of Directors Compensation Program. F2 — units will be payable in company common stock on the earlier of (a) five years from grant or (b) the date the reporting person leaves the board, unless a later date was elected.
• No 10b5-1 plan, tax-withholding sale, or exercise/sale activity is indicated in this filing.

Context
Deferred stock units (DSUs) are a form of equity compensation for directors that convert into shares at a future date (often used for retention and deferral of compensation). Because this is an award rather than a market purchase or sale, it should be viewed as routine director compensation and not a direct market signal of insider buying or selling.